NeurologyLive® Mind Moments®
By NeurologyLive
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by NeurologyLive
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 125
Description
Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders.
Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more.
For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .
| Episode | Date |
|---|---|
|
113: Lessons Learned in Alzheimer Drug Development
|
Apr 19, 2024 |
|
112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia
|
Apr 05, 2024 |
|
Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy
|
Mar 29, 2024 |
|
111: Reviewing ACTRIMS 2024
|
Mar 22, 2024 |
|
110: Differential Diagnosis of Sleep Disorders and Hypersomnias
|
Mar 08, 2024 |
|
109: AB126, Exosomes, and Cerebroprotection for Stroke
|
Feb 23, 2024 |
|
108: Advancing the Genetic Pool of Parkinson Disease
|
Feb 09, 2024 |
|
107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers
|
Jan 26, 2024 |
|
106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis
|
Jan 12, 2024 |
|
105: Recapping Conversations in Neurology From 2023
|
Dec 29, 2023 |
|
104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2
|
Dec 15, 2023 |
|
103: Advancing Epilepsy Care and Seizure Localization in Pediatrics
|
Dec 01, 2023 |
|
102: Potential of Gamma Sensory Stimulation in Alzheimer Disease
|
Nov 17, 2023 |
|
Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy
|
Nov 07, 2023 |
|
101: Ways to Enhance Neuromodulation in Parkinsonism
|
Nov 03, 2023 |
|
Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis
|
Oct 23, 2023 |
|
100: 2023 ECTRIMS-ACTRIMS Meeting Highlights
|
Oct 20, 2023 |
|
99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy
|
Oct 05, 2023 |
|
98: Uncovering Phenotypical Features of Narcolepsy Type 1
|
Sep 22, 2023 |
|
97: Identifying Gaps in Access to Parkinson Disease Care
|
Sep 08, 2023 |
|
96: Complexities With Cognitive Screening in Primary Care Settings
|
Aug 25, 2023 |
|
Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea
|
Aug 21, 2023 |
|
95: Expanding Potential for Long-Term Treatment in SMA
|
Aug 11, 2023 |
|
94: The Discussion Surrounding Lecanemab's Approval for Alzheimer Disease
|
Jul 28, 2023 |
|
93: Caring for Women With Parkinson Disease
|
Jul 14, 2023 |
|
92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
|
Jun 30, 2023 |
|
Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular Dystrophy
|
Jun 22, 2023 |
|
91: Assessing the Landscape of Sleep Disorder Care
|
Jun 16, 2023 |
|
90: Raising Stroke Awareness and Improving Clinical Care
|
Jun 02, 2023 |
|
89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS
|
May 19, 2023 |
|
88: 2023 AAN Annual Meeting Highlights
|
May 05, 2023 |
|
Special Episode: Tofersen Approved for SOD1 ALS
|
Apr 25, 2023 |
|
87: Severe Multiple Sclerosis and the CASA-MS Study
|
Apr 21, 2023 |
|
86: Pimavanserin and Atypical Antipsychotics to Treat Parkinson Disease Psychosis
|
Apr 07, 2023 |
|
85: Impact of Narcolepsy on Social Relationship Health in Adolescents
|
Mar 24, 2023 |
|
Special Episode: Trofinetide Approved for Rett Syndrome
|
Mar 13, 2023 |
|
84: Parkinson Disease Education for Community Providers
|
Mar 10, 2023 |
|
83: The ARISE Study and Using DMTs in RIS
|
Feb 24, 2023 |
|
82: Managing Seizures After Ischemic Stroke
|
Feb 10, 2023 |
|
81: Widening the Therapeutic Window in Parkinson Disease
|
Jan 27, 2023 |
|
80: Advancing Treatment for Rare Neuromuscular Disorders
|
Jan 13, 2023 |
|
Special Episode: Lecanemab Approved for Alzheimer Disease
|
Jan 09, 2023 |
|
79: A New Monoclonal for Alzheimer Disease
|
Dec 16, 2022 |
|
78: A Virtual Reality Platform for Parkinson Disease
|
Dec 02, 2022 |
|
77: A New Era of Myasthenia Gravis Treatment
|
Nov 18, 2022 |
|
76: ECTRIMS 2022 and the Latest in MS Advances
|
Nov 04, 2022 |
|
75: Focusing on the Future of Neurology
|
Oct 21, 2022 |
|
74: Prescription Digital Therapeutics for Insomnia
|
Oct 07, 2022 |
|
73: The Role of Palliative Care in Neurology
|
Sep 23, 2022 |
|
72: Updates in Epilepsy Treatment
|
Sep 09, 2022 |
|
71: Pediatric Sleep and School Start Times
|
Aug 26, 2022 |
|
70: Raising Awareness of Acute Flaccid Myelitis
|
Aug 12, 2022 |
|
69: The Widespread Effects of DMT Waste in Multiple Sclerosis
|
Jul 29, 2022 |
|
68: Updates in Essential Tremor Care
|
Jul 15, 2022 |
|
67: Mental Health and Advocacy in Pediatric Migraine
|
Jul 01, 2022 |
|
66: 2022 SLEEP Annual Meeting Highlights
|
Jun 17, 2022 |
|
Special Episode: Aducanumab and Anti-Amyloid-ß, One Year Later
|
Jun 07, 2022 |
|
65: 2022 CMSC Annual Meeting Highlights
|
Jun 04, 2022 |
|
64: Genetics, Advocacy, and Big Data in ALS
|
May 20, 2022 |
|
63: Moving Migraine Toward Personalized Care
|
May 06, 2022 |
|
62: Advanced Therapeutics in Parkinson and Movement Disorders
|
Apr 22, 2022 |
|
61: 2022 AAN Annual Meeting Highlights
|
Apr 09, 2022 |
|
Special Episode: Ganaxolone Approved for CDD, Fenfluramine Approved for LGS
|
Mar 30, 2022 |
|
60: Improving Care and Raising Awareness for NMOSD
|
Mar 25, 2022 |
|
Special Episode: Heart Health in Narcolepsy
|
Mar 18, 2022 |
|
59: AASM's Push to End Daylight Saving Time
|
Mar 11, 2022 |
|
58: Addressing Parkinson Disease Virtually With Prime PD
|
Feb 25, 2022 |
|
57: Invisible Symptoms: Cognition and MS
|
Feb 11, 2022 |
|
56: Epstein-Barr Virus's Relationship With Multiple Sclerosis
|
Jan 28, 2022 |
|
55: Treating Headache in the Emergency Department
|
Jan 14, 2022 |
|
Special Episode: Daridorexant Approved for Insomnia
|
Jan 11, 2022 |
|
54: The Shortage of Neurologists
|
Dec 31, 2021 |
|
53: A Landmark Year for Alzheimer Disease
|
Dec 17, 2021 |
|
52: Treating Pediatric Migraine
|
Dec 03, 2021 |
|
51: The State of Sleep Medicine
|
Nov 19, 2021 |
|
50: Genetic Testing for Huntington Disease
|
Nov 05, 2021 |
|
49: Altering the View of MS With a Topographical Model
|
Oct 22, 2021 |
|
48: RapidAI's Effect on Stroke Imaging
|
Oct 08, 2021 |
|
47: Incorporating Physical Therapy Into MS Care
|
Sep 24, 2021 |
|
46: Tackling Barriers to Migraine Care
|
Sep 10, 2021 |
|
45: Small Victories: Advancing Care in Parkinson Disease
|
Aug 27, 2021 |
|
44: AHA/ASA Updates to the Stroke Care Model
|
Aug 13, 2021 |
|
43: Is Telehealth Here to Stay for Alzheimer Disease Care?
|
Jul 30, 2021 |
|
42: The Importance of Sleep for Overall Health
|
Jul 16, 2021 |
|
41: Consensus MRI Guidelines for MS
|
Jul 02, 2021 |
|
40: SLEEP 2021: Topline Data, Telemedicine, and Takeaways
|
Jun 18, 2021 |
|
39: A Controversial FDA Decision
|
Jun 11, 2021 |
|
38: Advancing MS Care and Awareness
|
Jun 04, 2021 |
|
37: The Impact of Awareness Efforts in ALS
|
May 21, 2021 |
|
36: Zavegepant and the Gepant Class for Migraine Care
|
May 07, 2021 |
|
35: Highlights From the AAN Annual Meeting
|
Apr 30, 2021 |
|
34: Hope and the Huntington Disease Pipeline
|
Apr 23, 2021 |
|
33: Problem Recognition: Cerebral Palsy Diagnosis
|
Apr 09, 2021 |
|
32: The Gaps in Migraine Care for Women
|
Mar 26, 2021 |
|
31: The Pipeline Pendulum in Parkinson Disease
|
Mar 12, 2021 |
|
30: Cognitive Behaviorial Therapy for Insomnia
|
Feb 26, 2021 |
|
29: Developing A Seizure Action Plan
|
Feb 12, 2021 |
|
28: The Multiple Sclerosis Patient Journey
|
Jan 29, 2021 |
|
27: Short, Sudden, Strange, Similar Spells
|
Jan 15, 2021 |
|
26: Digital Approaches to Comprehensive Care in MS
|
Jan 01, 2021 |
|
25: 2020 Wrap Up: Silver Linings
|
Dec 31, 2020 |
|
24: Aducanumab and Alzheimer Disease Clinical Trials
|
Dec 18, 2020 |
|
23: Real-World Acute Migraine Care
|
Dec 04, 2020 |
|
22: Capitalizing on Collaboration in Neurology Care
|
Nov 20, 2020 |
|
21: How Social Isolation Can Affect Disease Severity
|
Nov 06, 2020 |
|
20: Taking Steps to Advance Sleep Care
|
Oct 23, 2020 |
|
19: The Vascular Implications of Alzheimer Disease
|
Oct 09, 2020 |
|
18: Preventing Tonic-Clonic Seizures in Refractory Epilepsy
|
Sep 25, 2020 |
|
17: The Metamorphosis of Migraine: Discovery and Development
|
Sep 11, 2020 |
|
16: Personalizing Our Approach to Medication Adherence in Parkinson Disease
|
Aug 28, 2020 |
|
15: A New Approval: The SMA Treatment Landscape
|
Aug 14, 2020 |
|
14: Trends in the Alzheimer Clinical Pipeline
|
Jul 31, 2020 |
|
13: Sequencing SNPs in Huntington Disease
|
Jul 17, 2020 |
|
12: Masculinity and Multiple Sclerosis
|
Jun 26, 2020 |
|
11: Exploring the Link Between Stroke and COVID-19
|
Jun 05, 2020 |
|
10: Neurology and COVID-19: Perspectives From the Front Line
|
May 15, 2020 |
|
9: Innovation in the Parkinson Disease Pipeline
|
Apr 17, 2020 |
|
8: Adapting Neurologic Care During the COVID-19 Pandemic
|
Mar 20, 2020 |
|
7: No Relief: Rising MS Drug Prices
|
Feb 11, 2020 |
|
6: Time Is Brain: Why EMS Transport Protocols Matter
|
Jan 17, 2020 |
|
5: Gut Bacteria and the Brain: An Evolving Role in Epilepsy
|
Dec 30, 2019 |
|
4: Only the Beginning: Advancing Migraine Treatment
|
Nov 14, 2019 |
|
3: Using Technology to Broaden Stroke Care
|
Oct 03, 2019 |
|
2: Alzheimer Disease Update: Is Amyloid Really Dead?
|
Aug 19, 2019 |
|
1: State of CBD: Not All Cannabidiol Is Created Equal
|
Aug 05, 2019 |